BioCryst Pharmaceuticals ...

NASDAQ: BCRX · Real-Time Price · USD
8.38
0.01 (0.12%)
At close: Aug 18, 2025, 3:59 PM
8.35
-0.42%
After-hours: Aug 18, 2025, 07:05 PM EDT

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals reported an annual revenue of $450.71M, reflecting a 36% growth. For the quarter ending June 30, 2025, BioCryst Pharmaceuticals generated $163.35M in revenue.
Revenue (ttm)
450.71M
Revenue Growth
36%
Price / Sales Ratio
3.45
Revenue / Employee
777.09K
Employees
580
Market Cap
1.76B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 450.71M +36.00%
Dec 31, 2023 331.41M +22.37%
Dec 31, 2022 270.83M +72.31%
Dec 31, 2021 157.17M +782.38%
Dec 31, 2020 17.81M -63.53%
Dec 31, 2019 48.84M +136.45%
Dec 31, 2018 20.65M -18.00%
Dec 31, 2017 25.19M -4.43%
Dec 31, 2016 26.35M -45.39%
Dec 31, 2015 48.26M +254.62%
Dec 31, 2014 13.61M -21.48%
Dec 31, 2013 17.33M -34.09%
Dec 31, 2012 26.29M +33.85%
Dec 31, 2011 19.64M -69.07%
Dec 31, 2010 63.5M -14.87%
Dec 31, 2009 74.59M +31.87%
Dec 31, 2008 56.56M -20.60%
Dec 31, 2007 71.24M +1046.79%
Dec 31, 2006 6.21M +3990.38%
Dec 31, 2005 151.87K -54.92%
Dec 31, 2004 336.9K -79.38%
Dec 31, 2003 1.63M -7.92%
Dec 31, 2002 1.77M -84.10%
Dec 31, 2001 11.16M +236.52%
Dec 31, 2000 3.32M +32.62%
Dec 31, 1999 2.5M -60.94%
Dec 31, 1998 6.4M +540.00%
Dec 31, 1997 1M -62.96%
Dec 31, 1996 2.7M +1250.00%
Dec 31, 1995 200K -71.43%
Dec 31, 1994 700K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.